{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:26:25Z","timestamp":1786123585857,"version":"build-2736575974"},"reference-count":78,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The use of antidepressants is increasing globally. Despite their obvious benefits, ongoing use of these medications is often not properly monitored or deprescribed when a person returns to better mental health. In addition, providing prescriptions to those who do not have clinical depression leads to personal and societal cost burdens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This trial aims to assess the clinical effectiveness and cost-effectiveness of an online support tool designed to help patients with mild to no symptoms of depression and their general practitioners manage the careful and appropriate tapering and cessation of antidepressants at 6 months, and compare the effectiveness to that of usual care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This stratified, single-blind, parallel, 2-arm, superiority randomized controlled trial includes Australian primary care patients (aged 18-75 years) with mild to no symptoms of depression who have been on antidepressant medication for longer than 12 months. After obtaining informed consent, 340 eligible patients will be randomized in a 1:1 ratio to an active intervention arm and an attention control arm, with stratification by general practice or state of residence, if recruited via social media. Those in the active intervention arm will be asked to reduce their antidepressant use with the aid of a clinically guided online support tool (WiserAD), while those in the attention control arm will continue to receive usual care. Participants in both arms will be provided with information about antidepressants through the Beyond Blue website and followed up at 3, 6, 12, and 18 months to record antidepressant use, depression and anxiety symptom severity, quality of life, and health economic data. An intention-to-treat analysis will determine the clinical effectiveness of the online tool compared with usual care. The primary outcome is the between-arm difference in the proportion of participants who successfully cease medication use at 6 months and have mild or absent depressive symptoms. Cost-consequence and cost-utility analyses will be used to determine the cost-effectiveness of the intervention and its impact on quality of life, and comparisons will be made with usual care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study was funded by the National Health and Medical Research Council in 2019. At submission of this manuscript in July 2025, 310 participants have been randomized, and recruitment ongoing. The target number of 340 randomized participants was achieved in January 2026. Trial outcomes will be reported in peer-reviewed journals in Febraury 2027.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The WiserAD online support tool assists patients and their general practitioners with deprescribing and may lead to successful cessation of antidepressant medication, resulting in enhanced quality of life and cost savings over the longer term.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/81858","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:20:06Z","timestamp":1777317606000},"page":"e81858-e81858","source":"Crossref","is-referenced-by-count":0,"title":["Structured Online Support to Inform and Assist Antidepressant Deprescribing in Primary Care (WiserAD Tool): Protocol for a Pragmatic Randomized Controlled Trial"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3353-4108","authenticated-orcid":false,"given":"Catherine","family":"Kaylor-Hughes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3723-7645","authenticated-orcid":false,"given":"Amy","family":"Coe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0393-8734","authenticated-orcid":false,"given":"Patty","family":"Chondros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6822-2011","authenticated-orcid":false,"given":"Konstancja","family":"Densley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6359-8650","authenticated-orcid":false,"given":"Susan","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4902-9448","authenticated-orcid":false,"given":"Mary-Lou","family":"Chatterton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1405-7089","authenticated-orcid":false,"given":"Daniel","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4189-8403","authenticated-orcid":false,"given":"Timothy","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3811-2732","authenticated-orcid":false,"given":"Chee","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2149-9376","authenticated-orcid":false,"given":"Derelie","family":"Mangin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1618-9381","authenticated-orcid":false,"given":"Tony","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3243-8133","authenticated-orcid":false,"given":"Zoe","family":"Allnutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8836-7525","authenticated-orcid":false,"given":"Jane","family":"Gunn AO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"issue":"10128","key":"R1","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","journal-title":"Lancet"},{"issue":"1","key":"R2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0004867420979353","article-title":"The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders","volume":"55","author":"Malhi","journal-title":"Aust N Z J Psychiatry"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6103","article-title":"NICE updates antidepressant guidelines to reflect severity and length of withdrawal symptoms","author":"Iacobucci","journal-title":"BMJ"},{"key":"R4","unstructured":"Depression in adults: treatment and management. National Institute for Health and Care Excellence (NICE). 2022. URL: https:\/\/www.nice.org.uk\/guidance\/ng222\/resources\/depression-in-adults-treatment-and-management-pdf-66143832307909 [Accessed 22-07-2022]"},{"issue":"6","key":"R5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1370\/afm.2315","article-title":"Legacy drug-prescribing patterns in primary care","volume":"16","author":"Mangin","journal-title":"Ann Fam Med"},{"issue":"4","key":"R6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3399\/bjgpopen17X101265","article-title":"Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care","volume":"1","author":"Eveleigh","journal-title":"BJGP Open"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b3999","article-title":"Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database","volume":"339","author":"Moore","journal-title":"BMJ"},{"key":"R8","unstructured":"OECD Health Statistics. Organisation for Economic Co-operation and Development (OECD). URL: https:\/\/www.oecd.org\/health\/health-data.htm [Accessed 21-09-2023]"},{"key":"R9","unstructured":"Health at a glance 2019: OECD indicators. Organisation for Economic Co-operation and Development (OECD). URL: https:\/\/www.oecd.org\/en\/publications\/health-at-a-glance-2019_4dd50c09-en.html [Accessed 13-05-2026]"},{"key":"R10","unstructured":"Mental health. Australian Institute of Health and Welfare. URL: https:\/\/www.aihw.gov.au\/mental-health [Accessed 28-05-2026]"},{"issue":"8","key":"R11","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1377\/hlthaff.2010.1024","article-title":"Proportion of antidepressants prescribed without a psychiatric diagnosis is growing","volume":"30","author":"Mojtabai","journal-title":"Health Aff (Millwood)"},{"issue":"2","key":"R12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024051","article-title":"What proportion of initially prescribed antidepressants is still being prescribed chronically after 5 years in general practice? A longitudinal cohort analysis","volume":"9","author":"Verhaak","journal-title":"BMJ Open"},{"issue":"4","key":"R13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/0004867419898761","article-title":"Antidepressant treatment for primary care patients with depressive symptoms: data from the  longitudinal cohort study","volume":"54","author":"Davidson","journal-title":"Aust N Z J Psychiatry"},{"issue":"2","key":"R14","first-page":"105","volume":"5","author":"Cruickshank","journal-title":"Ment Health Fam Med"},{"issue":"3","key":"R15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/13811110590929488","article-title":"Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years\u2019 follow-up","volume":"9","author":"Angst","journal-title":"Arch Suicide Res"},{"issue":"2","key":"R16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1017\/S0033291713000706","article-title":"Incidence and predictors of suicide attempts among primary-care patients with depressive disorders: a 5-year prospective study","volume":"44","author":"Riihim\u00e4ki","journal-title":"Psychol Med"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.01.055","article-title":"What factors influence long-term antidepressant use in primary care? Findings from the Australian diamond cohort study","volume":"176","author":"Ambresin","journal-title":"J Affect Disord"},{"key":"R18","unstructured":"Frellick M . Antibiotics, antidepressants dominate new FDA watch list. Medscape. 2018. URL: https:\/\/www.medscape.com\/viewarticle\/891540 [Accessed 21-09-2023]"},{"issue":"5","key":"R19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000477940","article-title":"The mortality and myocardial effects of antidepressants are moderated by preexisting cardiovascular disease: a meta-analysis","volume":"86","author":"Maslej","journal-title":"Psychother Psychosom"},{"issue":"6","key":"R20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/ajg.2014.82","article-title":"Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis","volume":"109","author":"Anglin","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"R21","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1022-x","article-title":"Antidepressant use and risk of adverse outcomes in people aged 20-64 years: cohort study using a primary care database","volume":"16","author":"Coupland","journal-title":"BMC Med"},{"issue":"7","key":"R22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182088","article-title":"The risk of new-onset diabetes in antidepressant users - a systematic review and meta-analysis","volume":"12","author":"Salvi","journal-title":"PLoS One"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2018.10.107","article-title":"Barriers and facilitators to discontinuing antidepressant use: a systematic review and thematic synthesis","volume":"245","author":"Maund","journal-title":"J Affect Disord"},{"issue":"4","key":"R24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/02813432.2021.2006487","article-title":"\u201cNever change a winning team\u201d: GPs\u2019 perspectives on discontinuation of long-term antidepressants","volume":"39","author":"Ellen","journal-title":"Scand J Prim Health Care"},{"issue":"2","key":"R25","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv076","article-title":"Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta-analyses of controlled trials","volume":"19","author":"Sim","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"3","key":"R26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/aje\/kwp142","article-title":"Duration of antidepressant drug treatment and its influence on risk of relapse\/recurrence: immortal and neglected time bias","volume":"170","author":"Gardarsdottir","journal-title":"Am J Epidemiol"},{"key":"R27","unstructured":"Mangin D Dowson C Toop L et al. The effectiveness of maintenance SSRI treatment in primary care depression to prevent recurrence: multicentre double blinded placebo controlled RCT. Presented at: 2015 NAPCRG Annual Meeting; Oct 24-28, 2026; Canc\u00fan, Mexico. URL: https:\/\/napcrg.org\/conferences\/36\/sessions\/14867 [Accessed 28-05-2026]"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013495","article-title":"Discontinuation of long-term antidepressant use for depressive and anxiety disorders in adults","author":"Van Leeuwen","journal-title":"Cochrane Database Syst Rev"},{"issue":"604","key":"R29","doi-asserted-by":"publisher","first-page":"e773","DOI":"10.3399\/bjgp12X658304","article-title":"Reviewing long-term antidepressants can reduce drug burden: a prospective observational cohort study","volume":"62","author":"Johnson","journal-title":"Br J Gen Pract"},{"issue":"4","key":"R30","doi-asserted-by":"publisher","DOI":"10.3399\/bjgpopen17X101265","article-title":"Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care","volume":"1","author":"Eveleigh","journal-title":"BJGP Open"},{"issue":"1","key":"R31","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04338-7","article-title":"REDUCE (Reviewing long-term antidepressant use by careful monitoring in everyday practice) internet and telephone support to people coming off long-term antidepressants: protocol for a randomised controlled trial","volume":"21","author":"Kendrick","journal-title":"Trials"},{"issue":"6","key":"R32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.18383","article-title":"Internet and telephone support for discontinuing long-term antidepressants: the REDUCE cluster randomized trial","volume":"7","author":"Kendrick","journal-title":"JAMA Netw Open"},{"issue":"10","key":"R33","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40266-013-0106-8","article-title":"Patient barriers to and enablers of deprescribing: a systematic review","volume":"30","author":"Reeve","journal-title":"Drugs Aging"},{"issue":"651","key":"R34","doi-asserted-by":"publisher","first-page":"e708","DOI":"10.3399\/bjgp16X686641","article-title":"Long-term antidepressant use: a qualitative study on perspectives of patients and GPs in primary care","volume":"66","author":"Bosman","journal-title":"Br J Gen Pract"},{"issue":"8","key":"R35","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1176\/appi.ps.201500359","article-title":"A prescription for \u201cdeprescribing\u201d in psychiatry","volume":"67","author":"Gupta","journal-title":"Psychiatr Serv"},{"issue":"7","key":"R36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027837","article-title":"Helping people discontinue long-term antidepressants: views of health professionals in UK primary care","volume":"9","author":"Bowers","journal-title":"BMJ Open"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1177\/20451253211067656","article-title":"Clinical practice guideline recommendations on tapering and discontinuing antidepressants for depression: a systematic review","volume":"12","author":"S\u00f8rensen","journal-title":"Ther Adv Psychopharmacol"},{"key":"R38","unstructured":"Too much medicine. Royal Australian College of General Practitioners (RACGP). URL: https:\/\/www.racgp.org.au\/advocacy\/position-statements\/view-all-position-statements\/clinical-and-practice-management\/too-much-medicine [Accessed 07-05-2019]"},{"issue":"19","key":"R39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/psb.1389","article-title":"Long\u2010term antidepressant treatment: time for a review?","volume":"26","author":"Kendrick","journal-title":"Prescriber"},{"issue":"2","key":"R40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-078179","article-title":"Understanding Australian general practice patients\u2019 decisions to deprescribe antidepressants in the WiserAD trial: a realist informed approach","volume":"14","author":"Coe","journal-title":"BMJ Open"},{"issue":"5","key":"R41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/13561820.2013.785503","article-title":"Shared decision-making and interprofessional collaboration in mental healthcare: a qualitative study exploring perceptions of barriers and facilitators","volume":"27","author":"Chong","journal-title":"J Interprof Care"},{"key":"R42","unstructured":"Identifying essential components of an antidepressant deprescribing intervention. Society for Academic Primary Care. URL: https:\/\/sapc.ac.uk\/conference\/2017\/abstract\/identifying-essential-components-of-antidepressant-deprescribing [Accessed 21-09-2023]"},{"issue":"6","key":"R43","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/fampra\/cmm069","article-title":"A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors","volume":"24","author":"Leydon","journal-title":"Fam Pract"},{"issue":"6","key":"R44","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1080\/17843286.2021.2024384","article-title":"Should I, can I, dare I? Patients\u2019 view on stopping long-term antidepressant use, a qualitative study","volume":"77","author":"Van Leeuwen","journal-title":"Acta Clin Belg"},{"issue":"2","key":"R45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1179\/174592006X111003","article-title":"Better safe than sorry \u2014 why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study","volume":"2","author":"Verbeek-Heida","journal-title":"Chron Ill"},{"issue":"8","key":"R46","doi-asserted-by":"publisher","first-page":"474","DOI":"10.31128\/AJGP-03-20-5287","article-title":"Smoking cessation","volume":"49","author":"Zwar","journal-title":"Aust J Gen Pract"},{"key":"R47","unstructured":"Strengthening health systems for treating tobacco dependence in primary care. Part I: training for policy-makers: developing and implementing health systems policy to improve the delivery of brief tobacco interventions. World Health Organization. 2013. URL: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/b0e2322b-27f0-4bc7-a8a5-a3300c78209f\/content [Accessed 13-05-2026]"},{"key":"R48","unstructured":"Fiore MC Ja\u00e9n CR Baker TB et al. Treating tobacco use and dependence: 2008 update: clinical practice guideline. US Centers for Disease Control and Prevention (CDC). 2008. URL: https:\/\/stacks.cdc.gov\/view\/cdc\/6964 [Accessed 13-05-2026]"},{"issue":"1","key":"R49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1370\/afm.2336","article-title":"Managing antidepressant discontinuation: a systematic review","volume":"17","author":"Maund","journal-title":"Ann Fam Med"},{"issue":"12","key":"R50","doi-asserted-by":"publisher","DOI":"10.2196\/42526","article-title":"General practice patients\u2019 experiences and perceptions of the WiserAD structured web-based support tool for antidepressant deprescribing: protocol for a mixed methods case study with realist evaluation","volume":"11","author":"Coe","journal-title":"JMIR Res Protoc"},{"key":"R51","unstructured":"Antidepressant medication. Beyond Blue. URL: https:\/\/tinyurl.com\/8n4p7n9u [Accessed 13-05-2026]"},{"key":"R52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081660","article-title":"SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials","volume":"389","author":"Hr\u00f3bjartsson","journal-title":"BMJ"},{"issue":"9","key":"R53","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","journal-title":"J Gen Intern Med"},{"key":"R54","unstructured":"ICH harmonised guideline: guideline for good clinical practice E6(R3). International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. 2025. URL: https:\/\/database.ich.org\/sites\/default\/files\/ICH_E6%28R3%29_Step4_FinalGuideline_2025_0106.pdf [Accessed 13-05-2026]"},{"key":"R55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","journal-title":"J Biomed Inform"},{"issue":"10","key":"R56","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","journal-title":"Arch Intern Med"},{"issue":"1","key":"R57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08870449908407311","article-title":"The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication","volume":"14","author":"Horne","journal-title":"Psychol Health"},{"issue":"4","key":"R58","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10488-009-0239-6","article-title":"Development of the patient activation measure for mental health","volume":"37","author":"Green","journal-title":"Adm Policy Ment Health"},{"issue":"3","key":"R59","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1023\/a:1008815005736","article-title":"The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life","volume":"8","author":"Hawthorne","journal-title":"Qual Life Res"},{"issue":"10","key":"R60","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002759","article-title":"Measuring resource utilization: a systematic review of validated self-reported questionnaires","volume":"95","author":"Leggett","journal-title":"Medicine (Baltimore)"},{"key":"R61","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S213113","article-title":"Accountability in patient adherence","volume":"2019","author":"Oussedik","journal-title":"Patient Prefer Adherence"},{"key":"R62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijhcs.2018.01.004","article-title":"A practical approach to measuring user engagement with the refined user engagement scale (UES) and new UES short form","volume":"112","author":"O\u2019Brien","journal-title":"Int J Hum Comput Stud"},{"issue":"4 Pt 1","key":"R63","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1475-6773.2004.00269.x","article-title":"Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers","volume":"39","author":"Hibbard","journal-title":"Health Serv Res"},{"issue":"703","key":"R64","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.3399\/BJGP.2020.0783","article-title":"Matching depression management to severity prognosis in primary care: results of the Target-D randomised controlled trial","volume":"71","author":"Fletcher","journal-title":"Br J Gen Pract"},{"issue":"3","key":"R65","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S2215-0366(20)30517-4","article-title":"Clinical efficacy of a Decision Support Tool (Link-me) to guide intensity of mental health care in primary practice: a pragmatic stratified randomised controlled trial","volume":"8","author":"Fletcher","journal-title":"Lancet Psychiatry"},{"key":"R66","unstructured":"Pawson R Tilley N . Realistic Evaluation. SAGE Publications Ltd; 1997. ISBN: 9781473924857"},{"issue":"1","key":"R67","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-015-0237-x","article-title":"What\u2019s in a mechanism? Development of a key concept in realist evaluation","volume":"10","author":"Dalkin","journal-title":"Implement Sci"},{"key":"R68","doi-asserted-by":"crossref","unstructured":"Jovchelovitch S Bauer MW . Narrative interviewing. In: Bauer MW Gaskell G , editors. Qualitative Researching with Text, Image and Sound: A Practical Handbook for Social Research. SAGE Publications Ltd; 2000:57-74. [doi: 10.4135\/9781849209731.n4]","DOI":"10.4135\/9781849209731.n4"},{"issue":"8","key":"R69","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008567","article-title":"Protocol--the RAMESES II study: developing guidance and reporting standards for realist evaluation","volume":"5","author":"Greenhalgh","journal-title":"BMJ Open"},{"issue":"S12","key":"R70","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.5694\/j.1326-5377.2008.tb01874.x","article-title":"Who is identified when screening for depression is undertaken in general practice? Baseline findings from the Diagnosis, Management and Outcomes of Depression in Primary Care (diamond) longitudinal study","volume":"188","author":"Gunn","journal-title":"Med J Aust"},{"issue":"14","key":"R71","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1056\/NEJMoa2106356","article-title":"Maintenance or discontinuation of antidepressants in primary care","volume":"385","author":"Lewis","journal-title":"N Engl J Med"},{"issue":"3","key":"R72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149984","article-title":"Deprescribing in frail older people: a randomised controlled trial","volume":"11","author":"Potter","journal-title":"PLOS One"},{"key":"R73","unstructured":"Wiser about Anti Depressants (WiserAD). URL: https:\/\/wiserad.com.au\/ [Accessed 09-04-2026]"},{"issue":"4","key":"R74","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/1740774512450098","article-title":"Including all individuals is not enough: lessons for intention-to-treat analysis","volume":"9","author":"White","journal-title":"Clin Trials"},{"issue":"1","key":"R75","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"8","author":"Schulz","journal-title":"BMC Med"},{"key":"R76","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-14-6","article-title":"Prescribing ANtiDepressants Appropriately (PANDA): a cluster randomized controlled trial in primary care","volume":"14","author":"Muskens","journal-title":"BMC Fam Pract"},{"key":"R77","doi-asserted-by":"publisher","DOI":"10.1177\/2045125319872344","article-title":"Patients\u2019 attitudes to discontinuing not-indicated long-term antidepressant use: barriers and facilitators","volume":"9","author":"Eveleigh","journal-title":"Ther Adv Psychopharmacol"},{"issue":"1","key":"R78","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-023-07646-w","article-title":"RELEASE (REdressing Long-tErm Antidepressant uSE): protocol for a 3-arm pragmatic cluster randomised controlled trial effectiveness-implementation hybrid type-1 in general practice","volume":"24","author":"Wallis","journal-title":"Trials"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:55:10Z","timestamp":1786118110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e81858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":78,"URL":"https:\/\/doi.org\/10.2196\/81858","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"article-number":"v15i10128e81858"}}